Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers.
Thomas W. Uhde(Penn State Milton S. Hershey Medical Center), Robert M. Post(George Washington University), George N.M. Gurguis, Bernard J. Vittone(Center for Anxiety and Depression), David R. Rubinow, Bruce Black(University of North Carolina at Chapel Hill), J.P. Boulenger, D B Roscow, Marilla Geraci, Manuel E. Tancer(Wayne State University)
PubMed
February 1, 1992
Cited by 52
Related Papers
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
Neural substrates for voluntary suppression of negative affect: A functional magnetic resonance imaging study
|Biological Psychiatry|2005|904
Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders
|Journal of Affective Disorders|2000|871
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
|American Journal of Psychiatry|2013|754
Association between Amygdala Hyperactivity to Harsh Faces and Severity of Social Anxiety in Generalized Social Phobia
|Biological Psychiatry|2005|544